{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:57:50Z","timestamp":1790449070713,"version":"4.1.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"DOI":"10.1038\/s41433-026-04846-x","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:00:56Z","timestamp":1790445656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prelaminar optic neuritis in clinical practice: observations from five patients"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-4561","authenticated-orcid":false,"given":"Alexis","family":"Garc\u00eda-Sarre\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0344-9749","authenticated-orcid":false,"given":"Axel","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"4846_CR1","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","volume":"21","author":"A Petzold","year":"2022","unstructured":"Petzold A, Fraser CL, Abegg M, Alroughani R, Alshowaeir D, Alvarenga R, et al. Diagnosis and classification of optic neuritis. Lancet Neurol. 2022;21:1120\u201334.","journal-title":"Lancet Neurol"},{"key":"4846_CR2","first-page":"895","volume":"42","author":"P Hofman","year":"2001","unstructured":"Hofman P, Hoyng P, van der Werf F, Vrensen GF, Schlingemann RO. Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. Investig Ophthalmol Vis Sci. 2001;42:895\u2013901.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4846_CR3","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1038\/s41433-021-01614-x","volume":"35","author":"OR Marmoy","year":"2021","unstructured":"Marmoy OR, Viswanathan S. Clinical electrophysiology of the optic nerve and retinal ganglion cells. Eye. 2021;35:2386\u2013405.","journal-title":"Eye"},{"key":"4846_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/WNO.0000000000002423","volume":"46","author":"GT Plant","year":"2026","unstructured":"Plant GT. Comment: Clinical characteristics and treatment effects of chronic immunotherapy in idiopathic recurrent neuroretinitis and idiopathic recurrent papillitis: describing a potential new phenotype. J Neuroophthalmol. 2026;46:143\u20134.","journal-title":"J Neuroophthalmol"},{"key":"4846_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1159\/000547225","volume":"16","author":"N Ebrahimiadib","year":"2025","unstructured":"Ebrahimiadib N, Ghochani G, Yadegari S, Buchowicz BE, Shahgholi SS, Azarkish A, et al. Vision restoration of steroid-refractory prelaminar optic nerve inflammation with plasmapheresis: report of two cases and literature review. Case Rep Ophthalmol. 2025;16:567\u201374.","journal-title":"Case Rep Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04846-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04846-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04846-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:00:57Z","timestamp":1790445657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04846-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":5,"alternative-id":["4846"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04846-x","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"19 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AGS has received speaker honoraria from Amgen, Merck and Sanofi and travel support from Roche, Novartis and UCB Pharma, outside the submitted work. AP declares no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This case-note review was approved by the MEH Institutional Review Board (CaRs_32, 22 June 2025) and was conducted in accordance with the Declaration of Helsinki. Written informed consent for publication of clinical details and images was obtained from all patients.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}